ALK and non-small cell lung carcinoma: Alectinib hydrochloride (ALH), an anaplastic lymphoma receptor tyrosine kinase (ALK) inhibitor, is used for the treatment of ALK-positive locally advanced or metastatic non-small-cell lung cancer.